Chad C Hellmann

Remedium Capital Partners, Llc

Assets Managed

$281.15M

Holdings

Last Quarter

2026 - Q1

Filed Date

1d ago

Growth Rate

65.18%(2Q avg: 32.59%)

Sustained Growth

1 quarters

Portfolio positions

This chart displays the top 10 holdings in Remedium Capital Partners, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 6 positions.

Assets under management

The assets under management (AUM) of Remedium Capital Partners, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 281.15M in assets, with a quarterly growth rate of 65.18% and a 2-quarter average growth rate of 32.59%. The portfolio is managed by Chad C Hellmann, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ORKA Oruka Therapeutics Inc Recent Activity Increased 0.86%	27.32%	$76.796M 1.566M shares@ $49.05 avg price	Increased 0.86%
SYRE Spyre Therapeutics Inc Recent Activity	26.13%	$73.452M 1.456M shares@ $50.45 avg price
GLTO Galecto Inc Recent Activity Increased 1597.87%	18.85%	$52.978M 2.045M shares@ $25.9 avg price	Increased 1597.87%
APGE Apogee Therapeutics Inc Recent Activity	17.48%	$49.121M 583,591 shares@ $84.17 avg price
JBIO Jade Biosciences Inc Recent Activity	7.89%	$22.167M 1.578M shares@ $14.06 avg price
ur-1⤦ Crescent Biopharma Inc Recent Activity	2.37%	$6.636M 361,250 shares@ $18.38 avg price

1-6 of 6